Vimarsana
Biggest News Aggregation in the World

Page 12 - Alligator Bioscience News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Alligator Bioscience. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Alligator Bioscience Today - Breaking & Trending Today

Nasdaq Stockholm AB: Delisting of paid subscription shares in Alligator Bioscience AB (26/21) - Vimarsana News

Nasdaq Stockholm AB: Delisting of paid subscription shares in Alligator Bioscience AB (26/21)

The paid subscription shares in Alligator Bioscience AB will be delisted. Last trading day for ATORX BTA will be on February 26, 2021. Instrument: Paid subscription shares --------------------------------------- Short

Alligator Bioscience's rights issue oversubscribed - Vimarsana News

Alligator Bioscience's rights issue oversubscribed

Alligator Bioscience's rights issue oversubscribed STOCKHOLM, Jan. 27, 2021 /PRNewswire/ -- Alligator Bioscience AB (publ) ("Alligator" or the "Company") has completed the share issue with pre-emption rights for the Company's shareholders, which was resolved upon by the Board of Directors on December 15, 2020 pursuant to the authorization from the annual general meeting on May 5, 2020 (the "Rights Issue"). The subscription period ran from and including January 11, 2021 to and including January 25, 2021. Through the Rights Issue, Alligator receives approximately SEK 86 million before deductio...

The subscription period in Alligator Bioscience's rights issue commences today - Vimarsana News

The subscription period in Alligator Bioscience's rights issue commences today

The subscription period in Alligator Bioscience's rights issue commences today News provided by Share this article Share this article NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN OR INTO, THE UNITED STATES OF AMERICA, CANADA, NEW ZEALAND, SOUTH AFRICA, JAPAN, AUSTRALIA, SOUTH KOREA, HONG KONG, SWITZERLAND, SINGAPORE OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, DISTRIBUTION OR PUBLICATION WOULD BE UNLAWFUL OR REQUIRE REGISTRATION OR ANY OTHER MEASURE. STOCKHOLM, Jan. 11, 2021 /PRNewswire/ -- Today is the first day of the subscription period in Alligator Bioscien...

Alligator Bioscience publishes prospectus in connection with forthcoming rights issue - Vimarsana News

Alligator Bioscience publishes prospectus in connection with forthcoming rights issue

Alligator Bioscience publishes prospectus in connection with forthcoming rights issue STOCKHOLM, Dec. 30, 2020 /PRNewswire/ -- T he Board of Directors of Alligator Bioscience AB (publ) ("Alligator" or the "Company") has, in connection with the rights issue of shares which was resolved upon by the Board of Directors on December 15, 2020 pursuant to the authorization from the Annual General Meeting on May 5, 2020 (the "Rights Issue"), prepared a prospectus (the "Prospectus") that today has been approved and registered by the Swedish Financial Supervisory Authority. To ensure continued successfu...

Aptevo Therapeutics Inc. - Consensus Indicates Potential 82.2% Upside - Vimarsana News

Aptevo Therapeutics Inc. - Consensus Indicates Potential 82.2% Upside

9:52 am Aptevo Therapeutics Inc. found using ticker (APVO) now have 3 analysts covering the stock with the consensus suggesting a rating of ‘Buy’. The target price ranges between 69 and 64 and has a mean target at 65.67. Given that the stocks previous close was at 36.05 this now indicates there is a potential upside of 82.2%. The day 50 moving average is 39.86 and the 200 day MA is 15.73. The market cap for the company is $156m. Visit the company website at: http://aptevotherapeutics.com Aptevo Therapeutics Inc., a clinical-stage biotechnology company, engages in the discov...